Movement Disorders (revue)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Psychiatric comorbidities in dystonia: emerging concepts.

Identifieur interne : 000836 ( PubMed/Checkpoint ); précédent : 000835; suivant : 000837

Psychiatric comorbidities in dystonia: emerging concepts.

Auteurs : Mateusz Zurowski [Canada] ; William M. Mcdonald ; Susan Fox ; Laura Marsh

Source :

RBID : pubmed:23893448

English descriptors

Abstract

Psychiatric disorders are highly prevalent in patients with dystonia and have a profound effect on quality of life. Patients with dystonia frequently meet criteria for anxiety disorders, especially social phobia, and major depressive disorder. Deficits in emotional processing have also been demonstrated in some dystonia populations. Onset of psychiatric disturbances in patients with dystonia often precedes onset of motor symptoms, suggesting that the pathophysiology of dystonia itself contributes to the genesis of psychiatric disturbances. This article examines the hypothesis that mood and anxiety disorders are intrinsic to the neurobiology of dystonia, citing the available literature, which is derived mostly from research on focal isolated dystonias. Limitations of studies are identified, and the role of emotional reactivity, especially in the context of pain secondary to dystonia, is recognized. Available evidence underscores the need to develop dystonia assessment tools that incorporate psychiatric measures. Such tools would allow for a better understanding of the full spectrum of dystonia presentations and facilitate research on the treatment of dystonia as well as the treatment of psychiatric illnesses in the context of dystonia. This article, solicited for a special Movement Disorders issue on novel research findings and emerging concepts in dystonia, addresses the following issues: (1) To what extent are psychiatric disturbances related to the pathophysiology of dystonia? (2) What is the impact of psychiatric disturbances on outcome measures of current assessment tools for dystonia? (3) How do psychiatric comorbidities influence the treatment of dystonia? Answers to these questions will lead to an increased appreciation of psychiatric disorders in dystonia, a better understanding of brain physiology, more nuanced research questions pertaining to this population, better clinical scales that can be used to further patient management and research, and improved patient outcomes. © 2013 Movement Disorder Society.

DOI: 10.1002/mds.25501
PubMed: 23893448


Affiliations:


Links toward previous steps (curation, corpus...)


Links to Exploration step

pubmed:23893448

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Psychiatric comorbidities in dystonia: emerging concepts.</title>
<author>
<name sortKey="Zurowski, Mateusz" sort="Zurowski, Mateusz" uniqKey="Zurowski M" first="Mateusz" last="Zurowski">Mateusz Zurowski</name>
<affiliation wicri:level="4">
<nlm:affiliation>Department of Psychiatry, University of Toronto, University Health Network, Toronto, Ontario, Canada. mateusz.zurowski@uhn.ca</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Department of Psychiatry, University of Toronto, University Health Network, Toronto, Ontario</wicri:regionArea>
<orgName type="university">Université de Toronto</orgName>
<placeName>
<settlement type="city">Toronto</settlement>
<region type="state">Ontario</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Mcdonald, William M" sort="Mcdonald, William M" uniqKey="Mcdonald W" first="William M" last="Mcdonald">William M. Mcdonald</name>
</author>
<author>
<name sortKey="Fox, Susan" sort="Fox, Susan" uniqKey="Fox S" first="Susan" last="Fox">Susan Fox</name>
</author>
<author>
<name sortKey="Marsh, Laura" sort="Marsh, Laura" uniqKey="Marsh L" first="Laura" last="Marsh">Laura Marsh</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2013">2013</date>
<idno type="doi">10.1002/mds.25501</idno>
<idno type="RBID">pubmed:23893448</idno>
<idno type="pmid">23893448</idno>
<idno type="wicri:Area/PubMed/Corpus">000809</idno>
<idno type="wicri:Area/PubMed/Curation">000809</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000836</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Psychiatric comorbidities in dystonia: emerging concepts.</title>
<author>
<name sortKey="Zurowski, Mateusz" sort="Zurowski, Mateusz" uniqKey="Zurowski M" first="Mateusz" last="Zurowski">Mateusz Zurowski</name>
<affiliation wicri:level="4">
<nlm:affiliation>Department of Psychiatry, University of Toronto, University Health Network, Toronto, Ontario, Canada. mateusz.zurowski@uhn.ca</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Department of Psychiatry, University of Toronto, University Health Network, Toronto, Ontario</wicri:regionArea>
<orgName type="university">Université de Toronto</orgName>
<placeName>
<settlement type="city">Toronto</settlement>
<region type="state">Ontario</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Mcdonald, William M" sort="Mcdonald, William M" uniqKey="Mcdonald W" first="William M" last="Mcdonald">William M. Mcdonald</name>
</author>
<author>
<name sortKey="Fox, Susan" sort="Fox, Susan" uniqKey="Fox S" first="Susan" last="Fox">Susan Fox</name>
</author>
<author>
<name sortKey="Marsh, Laura" sort="Marsh, Laura" uniqKey="Marsh L" first="Laura" last="Marsh">Laura Marsh</name>
</author>
</analytic>
<series>
<title level="j">Movement disorders : official journal of the Movement Disorder Society</title>
<idno type="eISSN">1531-8257</idno>
<imprint>
<date when="2013" type="published">2013</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Comorbidity</term>
<term>Dystonia (epidemiology)</term>
<term>Humans</term>
<term>Mental Disorders (epidemiology)</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en">
<term>Dystonia</term>
<term>Mental Disorders</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Comorbidity</term>
<term>Humans</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Psychiatric disorders are highly prevalent in patients with dystonia and have a profound effect on quality of life. Patients with dystonia frequently meet criteria for anxiety disorders, especially social phobia, and major depressive disorder. Deficits in emotional processing have also been demonstrated in some dystonia populations. Onset of psychiatric disturbances in patients with dystonia often precedes onset of motor symptoms, suggesting that the pathophysiology of dystonia itself contributes to the genesis of psychiatric disturbances. This article examines the hypothesis that mood and anxiety disorders are intrinsic to the neurobiology of dystonia, citing the available literature, which is derived mostly from research on focal isolated dystonias. Limitations of studies are identified, and the role of emotional reactivity, especially in the context of pain secondary to dystonia, is recognized. Available evidence underscores the need to develop dystonia assessment tools that incorporate psychiatric measures. Such tools would allow for a better understanding of the full spectrum of dystonia presentations and facilitate research on the treatment of dystonia as well as the treatment of psychiatric illnesses in the context of dystonia. This article, solicited for a special Movement Disorders issue on novel research findings and emerging concepts in dystonia, addresses the following issues: (1) To what extent are psychiatric disturbances related to the pathophysiology of dystonia? (2) What is the impact of psychiatric disturbances on outcome measures of current assessment tools for dystonia? (3) How do psychiatric comorbidities influence the treatment of dystonia? Answers to these questions will lead to an increased appreciation of psychiatric disorders in dystonia, a better understanding of brain physiology, more nuanced research questions pertaining to this population, better clinical scales that can be used to further patient management and research, and improved patient outcomes. © 2013 Movement Disorder Society.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">23893448</PMID>
<DateCreated>
<Year>2013</Year>
<Month>07</Month>
<Day>29</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>02</Month>
<Day>26</Day>
</DateCompleted>
<DateRevised>
<Year>2014</Year>
<Month>11</Month>
<Day>13</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1531-8257</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>28</Volume>
<Issue>7</Issue>
<PubDate>
<Year>2013</Year>
<Month>Jun</Month>
<Day>15</Day>
</PubDate>
</JournalIssue>
<Title>Movement disorders : official journal of the Movement Disorder Society</Title>
<ISOAbbreviation>Mov. Disord.</ISOAbbreviation>
</Journal>
<ArticleTitle>Psychiatric comorbidities in dystonia: emerging concepts.</ArticleTitle>
<Pagination>
<MedlinePgn>914-20</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1002/mds.25501</ELocationID>
<Abstract>
<AbstractText>Psychiatric disorders are highly prevalent in patients with dystonia and have a profound effect on quality of life. Patients with dystonia frequently meet criteria for anxiety disorders, especially social phobia, and major depressive disorder. Deficits in emotional processing have also been demonstrated in some dystonia populations. Onset of psychiatric disturbances in patients with dystonia often precedes onset of motor symptoms, suggesting that the pathophysiology of dystonia itself contributes to the genesis of psychiatric disturbances. This article examines the hypothesis that mood and anxiety disorders are intrinsic to the neurobiology of dystonia, citing the available literature, which is derived mostly from research on focal isolated dystonias. Limitations of studies are identified, and the role of emotional reactivity, especially in the context of pain secondary to dystonia, is recognized. Available evidence underscores the need to develop dystonia assessment tools that incorporate psychiatric measures. Such tools would allow for a better understanding of the full spectrum of dystonia presentations and facilitate research on the treatment of dystonia as well as the treatment of psychiatric illnesses in the context of dystonia. This article, solicited for a special Movement Disorders issue on novel research findings and emerging concepts in dystonia, addresses the following issues: (1) To what extent are psychiatric disturbances related to the pathophysiology of dystonia? (2) What is the impact of psychiatric disturbances on outcome measures of current assessment tools for dystonia? (3) How do psychiatric comorbidities influence the treatment of dystonia? Answers to these questions will lead to an increased appreciation of psychiatric disorders in dystonia, a better understanding of brain physiology, more nuanced research questions pertaining to this population, better clinical scales that can be used to further patient management and research, and improved patient outcomes. © 2013 Movement Disorder Society.</AbstractText>
<CopyrightInformation>© 2013 Movement Disorder Society.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Zurowski</LastName>
<ForeName>Mateusz</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Department of Psychiatry, University of Toronto, University Health Network, Toronto, Ontario, Canada. mateusz.zurowski@uhn.ca</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>McDonald</LastName>
<ForeName>William M</ForeName>
<Initials>WM</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Fox</LastName>
<ForeName>Susan</ForeName>
<Initials>S</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Marsh</LastName>
<ForeName>Laura</ForeName>
<Initials>L</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>NS065701</GrantID>
<Acronym>NS</Acronym>
<Agency>NINDS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>U54 NS065701</GrantID>
<Acronym>NS</Acronym>
<Agency>NINDS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>U54 NS065701</GrantID>
<Acronym>NS</Acronym>
<Agency>NINDS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Mov Disord</MedlineTA>
<NlmUniqueID>8610688</NlmUniqueID>
<ISSNLinking>0885-3185</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="Cites">
<RefSource>Arch Gen Psychiatry. 1994 Jan;51(1):8-19</RefSource>
<PMID Version="1">8279933</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Arch Gen Psychiatry. 1992 Aug;49(8):624-9</RefSource>
<PMID Version="1">1637252</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>N Engl J Med. 2005 Feb 3;352(5):459-67</RefSource>
<PMID Version="1">15689584</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Am J Psychiatry. 2005 Jun;162(6):1171-8</RefSource>
<PMID Version="1">15930066</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Adv Neurol. 2005;96:291-319</RefSource>
<PMID Version="1">16383228</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mov Disord. 2006 Jan;21(1):78-82</RefSource>
<PMID Version="1">16114021</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mov Disord. 2006 Oct;21(10):1636-40</RefSource>
<PMID Version="1">16856133</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neurology. 2007 Feb 13;68(7):522-4</RefSource>
<PMID Version="1">17296918</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mov Disord. 2007 Feb 15;22(3):341-7</RefSource>
<PMID Version="1">17216640</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Neurol Neurosurg Psychiatry. 2007 Dec;78(12):1398-400</RefSource>
<PMID Version="1">17615166</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mov Disord. 2008 Apr 15;23(5):641-5</RefSource>
<PMID Version="1">18220295</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mov Disord. 2008 Nov 15;23(15):2129-70</RefSource>
<PMID Version="1">19025984</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Neurol. 2008 Nov;255(11):1750-5</RefSource>
<PMID Version="1">19156488</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Clin Neurol Neurosurg. 2009 Feb;111(2):161-4</RefSource>
<PMID Version="1">18995953</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Hand Ther. 2009 Apr-Jun;22(2):144-54; quiz 155</RefSource>
<PMID Version="1">19278826</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Brain. 2009 Aug;132(Pt 8):2005-25</RefSource>
<PMID Version="1">19578124</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Affect Disord. 2009 Oct;117 Suppl 1:S15-25</RefSource>
<PMID Version="1">19682749</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Neurol Neurosurg Psychiatry. 2009 Oct;80(10):1176-9</RefSource>
<PMID Version="1">19465414</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mov Disord. 2010 Mar 15;25(4):459-65</RefSource>
<PMID Version="1">20108377</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Brain. 2010 May;133(Pt 5):1552-64</RefSource>
<PMID Version="1">20350935</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Psychiatr Clin North Am. 2010 Sep;33(3):557-77</RefSource>
<PMID Version="1">20599133</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mov Disord. 2010 Oct 15;25(13):2249-52</RefSource>
<PMID Version="1">20737548</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Eur J Neurol. 2011 Feb;18(2):329-36</RefSource>
<PMID Version="1">20666836</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mov Disord. 2011 Feb 15;26(3):539-42</RefSource>
<PMID Version="1">21370273</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mov Disord. 2011 Jun;26(7):1206-17</RefSource>
<PMID Version="1">21484874</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Neurol Neurosurg Psychiatry. 2000 Feb;68(2):227-9</RefSource>
<PMID Version="1">10644795</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mov Disord. 2001 Mar;16(2):280-5</RefSource>
<PMID Version="1">11295781</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mov Disord. 2011 Oct;26(12):2274-8</RefSource>
<PMID Version="1">21830232</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Neurol Neurosurg Psychiatry. 2012 Aug;83(8):814-20</RefSource>
<PMID Version="1">22626943</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mov Disord. 2013 Jun 15;28(7):863-73</RefSource>
<PMID Version="1">23649720</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Behav Ther Exp Psychiatry. 2006 Sep;37(3):239-46</RefSource>
<PMID Version="1">16162332</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Neurol Neurosurg Psychiatry. 2001 Oct;71(4):499-504</RefSource>
<PMID Version="1">11561034</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Neurol Neurosurg Psychiatry. 2002 May;72(5):608-14</RefSource>
<PMID Version="1">11971047</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Neurol. 2002 Jul;249(7):842-6</RefSource>
<PMID Version="1">12140667</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mov Disord. 2002 Jul;17(4):838-41</RefSource>
<PMID Version="1">12210891</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Depress Anxiety. 2002;16(3):100-3</RefSource>
<PMID Version="1">12415533</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Nerv Ment Dis. 2003 Jul;191(7):465-73</RefSource>
<PMID Version="1">12891094</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neurology. 2004 Aug 24;63(4):631-7</RefSource>
<PMID Version="1">15326234</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mov Disord. 2004 Oct;19(10):1169-75</RefSource>
<PMID Version="1">15390020</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Adv Neurol. 1976;14:259-76</RefSource>
<PMID Version="1">941774</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mov Disord. 1991;6(2):119-26</RefSource>
<PMID Version="1">2057004</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Neurol Neurosurg Psychiatry. 1992 Mar;55(3):229-31</RefSource>
<PMID Version="1">1564490</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Psychosom Res. 1998 Jun;44(6):687-90</RefSource>
<PMID Version="1">9678750</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015897">Comorbidity</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004421">Dystonia</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000453">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001523">Mental Disorders</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000453">epidemiology</QualifierName>
</MeshHeading>
</MeshHeadingList>
<OtherID Source="NLM">NIHMS513956</OtherID>
<OtherID Source="NLM">PMC3842100</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">anxiety</Keyword>
<Keyword MajorTopicYN="N">depression</Keyword>
<Keyword MajorTopicYN="N">dystonia</Keyword>
<Keyword MajorTopicYN="N">psychiatry</Keyword>
<Keyword MajorTopicYN="N">social phobia</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="received">
<Year>2013</Year>
<Month>2</Month>
<Day>7</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="revised">
<Year>2013</Year>
<Month>3</Month>
<Day>29</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted">
<Year>2013</Year>
<Month>4</Month>
<Day>3</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2013</Year>
<Month>7</Month>
<Day>30</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2013</Year>
<Month>7</Month>
<Day>31</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2014</Year>
<Month>2</Month>
<Day>27</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="doi">10.1002/mds.25501</ArticleId>
<ArticleId IdType="pubmed">23893448</ArticleId>
<ArticleId IdType="pmc">PMC3842100</ArticleId>
<ArticleId IdType="mid">NIHMS513956</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations>
<list>
<country>
<li>Canada</li>
</country>
<region>
<li>Ontario</li>
</region>
<settlement>
<li>Toronto</li>
</settlement>
<orgName>
<li>Université de Toronto</li>
</orgName>
</list>
<tree>
<noCountry>
<name sortKey="Fox, Susan" sort="Fox, Susan" uniqKey="Fox S" first="Susan" last="Fox">Susan Fox</name>
<name sortKey="Marsh, Laura" sort="Marsh, Laura" uniqKey="Marsh L" first="Laura" last="Marsh">Laura Marsh</name>
<name sortKey="Mcdonald, William M" sort="Mcdonald, William M" uniqKey="Mcdonald W" first="William M" last="Mcdonald">William M. Mcdonald</name>
</noCountry>
<country name="Canada">
<region name="Ontario">
<name sortKey="Zurowski, Mateusz" sort="Zurowski, Mateusz" uniqKey="Zurowski M" first="Mateusz" last="Zurowski">Mateusz Zurowski</name>
</region>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/PubMed/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000836 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 000836 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    PubMed
   |étape=   Checkpoint
   |type=    RBID
   |clé=     pubmed:23893448
   |texte=   Psychiatric comorbidities in dystonia: emerging concepts.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i   -Sk "pubmed:23893448" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd   \
       | NlmPubMed2Wicri -a MovDisordV3 

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024